AU2003295473A1 - Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use - Google Patents

Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use

Info

Publication number: AU2003295473A1
Authority: AU; Australia
Prior art keywords: cartillage; chondrocytes; methods; preparing anti; angiogenic drug
Prior art date: 2002-11-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003295473A

Other versions

AU2003295473A8 (en

Inventor

Anna Wong

Kin-Ping Wong

Ming-Chung Wong

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Wackvom Ltd

Original Assignee

Wackvom Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-13

Filing date

2003-11-13

Publication date

2004-06-03

2003-11-13 Application filed by Wackvom Ltd filed Critical Wackvom Ltd

2004-06-03 Publication of AU2003295473A1 publication Critical patent/AU2003295473A1/en

2004-06-03 Publication of AU2003295473A8 publication Critical patent/AU2003295473A8/en

Status Abandoned legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5064—Endothelial cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Cell Biology (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Hematology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Zoology (AREA)
Virology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Tropical Medicine & Parasitology (AREA)
Developmental Biology & Embryology (AREA)
Pharmacology & Pharmacy (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AU2003295473A 2002-11-13 2003-11-13 Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use Abandoned AU2003295473A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US42625802P	2002-11-13	2002-11-13
US60/426,258		2002-11-13
PCT/US2003/036132 WO2004043401A2 (en)	2002-11-13	2003-11-13	Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use

Publications (2)

Publication Number	Publication Date
AU2003295473A1 true AU2003295473A1 (en)	2004-06-03
AU2003295473A8 AU2003295473A8 (en)	2004-06-03

Family

ID=32313127

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003295473A Abandoned AU2003295473A1 (en)	2002-11-13	2003-11-13	Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use

Country Status (3)

Country	Link
AU (1)	AU2003295473A1 (en)
TW (1)	TW200423951A (en)
WO (1)	WO2004043401A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20051572A1 (en) *	2005-08-12	2007-02-13	Alberto Astaldi	PHARMACEUTICAL COMPOSITION CONTAINING AS AN ACTIVE SUBSTANCE A PROTEIN FRACTION EXTRACTED FROM EMBRYOS OF OVIPARIANS IN THE PERIOD OF CELLULAR DIFFERENTIATION AND RELATIVE PREPARATION PROCESS
US20100111910A1 (en) *	2006-07-12	2010-05-06	Angioblast Systems, Inc.	Treatment of excessive neovascularization
AU2007201520A1 (en) *	2006-11-29	2008-06-12	Neville Trevor Wittenbaker	Comosition for the treatment of patients with kidney stones, gout - and arthritis
US9321993B2 (en)	2010-06-17	2016-04-26	The Trustees Of Columbia University In The City Of New York	Tissue culture method for producing cartilage using trimethylamine N-oxide and chondroitinase
WO2014038864A1 (en) *	2012-09-05	2014-03-13	아주대학교산학협력단	Composition for preventing and treating immune disease using human fetal cartilage-derived cells
JP7654240B2 (en)	2017-09-19	2025-04-01	マサチューセッツインスティテュートオブテクノロジー	Compositions and uses thereof for chimeric antigen receptor t cell therapy
CN108939043A (en) *	2018-08-27	2018-12-07	车路平	A kind of Shark cartilage glycoprotein and its anticancer purpose
AU2019346335B2 (en)	2018-09-28	2024-07-25	Massachusetts Institute Of Technology	Collagen-localized immunomodulatory molecules and methods thereof
EP3990491A1 (en)	2019-06-26	2022-05-04	Massachusetts Institute of Technology	Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
WO2021061648A1 (en)	2019-09-23	2021-04-01	Massachusetts Institute Of Technology	Methods and compositions for stimulation of endogenous t cell responses
JP2023517889A (en)	2020-03-10	2023-04-27	マサチューセッツインスティテュートオブテクノロジー	Compositions and methods for immunotherapy of NPM1c-positive cancers
CA3173527A1 (en)	2020-03-10	2021-09-16	Massachusetts Institute Of Technology	Methods for generating engineered memory-like nk cells and compositions thereof
US12433954B2 (en)	2020-05-01	2025-10-07	Massachusetts Institute Of Technology	Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs
WO2023081715A1 (en)	2021-11-03	2023-05-11	Viracta Therapeutics, Inc.	Combination of car t-cell therapy with btk inhibitors and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5401653A (en) *	1994-02-23	1995-03-28	Sea Run Holdings, Inc.	Method for culturing insect cells in a medium containing fish serum
BR0017224A (en) *	2000-04-18	2003-01-07	Ceteris Holding B V Amsterdam	Natural extract-based composition useful in preventing and treating skin wrinkles

2003
- 2003-11-13 TW TW092131904A patent/TW200423951A/en unknown
- 2003-11-13 AU AU2003295473A patent/AU2003295473A1/en not_active Abandoned
- 2003-11-13 WO PCT/US2003/036132 patent/WO2004043401A2/en not_active Ceased

Also Published As

Publication number	Publication date
TW200423951A (en)	2004-11-16
WO2004043401A3 (en)	2004-09-30
WO2004043401A2 (en)	2004-05-27
AU2003295473A8 (en)	2004-06-03

Publication	Publication Date	Title
EP1648316A4 (en)	2010-11-10	Vertebral retainer-distracter and method of using same
EP1661113A4 (en)	2010-01-06	System and method for real-time co-rendering of multiple attributes
IL164703A0 (en)	2005-12-18	ImidazoÄ1,2-AÜpyrazin-8-ylamines method of making and method of use thereof
EP1572262A3 (en)	2005-11-03	Method of delivering local anesthesia
AU2003284115A1 (en)	2004-05-04	Method of delivering local anesthesia
AU2003207356A1 (en)	2004-09-17	Therapeutic method and apparatus
GB0319817D0 (en)	2003-09-24	Microcapsules method for preparing same and use thereof
AU2002320659A1 (en)	2003-07-24	Bilateral prosthesis and method of delivery
TWI348923B (en)	2011-09-21	Pharmaceutical composition of rapid disintegrating tablet and method of preparing the same
AU2003295473A1 (en)	2004-06-03	Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use
AU2002325434A1 (en)	2004-02-23	Medicinal agent and method for curing erectile dysfunction
SG115668A1 (en)	2005-10-28	Projection system and method of use thereof
IL173469A0 (en)	2006-06-11	Dental implant system and method
EP1669051A4 (en)	2011-06-15	Medical container and its using method
AU2003292733A1 (en)	2004-07-29	Information delivering apparatus and information delivering method
AU2003252493A1 (en)	2005-01-28	Pharmaceutical composition containing decoy and method of using the same
AU2003224732A1 (en)	2003-10-13	Method of using anti-apoptotic factors in gene expression
AU2002246950A1 (en)	2003-07-30	Hydrocapsules and method of preparation
AU2003282593A1 (en)	2004-05-13	Polyphenolamine composition and method of use
GB0312561D0 (en)	2003-07-09	Apparatus and method of using same
AU2003303815A1 (en)	2004-08-23	Alanines compounds, method of preparing them and their use
GB0405940D0 (en)	2004-04-21	Lasers and methods of making them
AU2003276930A1 (en)	2004-11-23	Drug discovery method and apparatus
GB2394223B (en)	2007-05-16	Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation
AU2003221875A1 (en)	2003-10-27	Stabilizing surgical delivery apparatus and method of use

Legal Events

Date	Code	Title	Description
2005-07-28	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase